High-protein diet may increase risk of weight gain, death for those at risk for heart disease
the ONA take:
According to findings presented last week at the European Congress on Obesity in Prague, Czech Republic, researchers have found that a high-protein diet may increase the risk of weight gain and early death for those at risk for heart disease.
For the study, researchers analyzed data from over 7,000 men and women aged 55 and over without heart disease.
Researchers assessed their protein consumption for about 5 years using food questionnaires. Although participants did not have heart disease, they all had either type 2 diabetes or three or more risk factors for heart disease, such as hypertension, smoking, dyslipidemia, and obesity.
Results showed that when protein replaced fat, risk of death increased by 66% and when protein replaced carbohydrates, it was increased by 59%.
When protein replaced carbohydrates, participants had a 90% higher risk of gaining more than 10% of body weight.
Diets rich in animal protein have also been associated with an elevated risk of colon cancer, diabetes, and heart disease.
A high-protein diet may increase the risk of weight gain and early death for those at risk for heart disease.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|